ReadYourDNA

Diazepam (Valium)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Diazepam

What it is

Diazepam is a benzodiazepine: it strengthens the calming effect of the messenger GABA at its receptors in the brain. It is used for anxiety, muscle spasms, alcohol withdrawal and to stop prolonged seizures, and before some procedures. It and its active breakdown product last a long time in the body. It is sold as Valium, among other names.

How genes come into it

Diazepam is broken down by the liver enzymes CYP2C19 and CYP3A4. People with two low-function CYP2C19 copies (poor metabolizers, more common in East Asian populations) clear diazepam and its active breakdown product desmethyldiazepam more slowly, so the effect lasts longer; the US FDA lists an effect on drug levels. There is no CPIC or DPWG guideline, and the other studies on this page are single findings.

Published guidelines

Clinical guidelines that name a gene for Diazepam. They sort people into groups by the gene copies they carry.

US FDA: CYP2C19. Likely Poor Metabolizer · Poor Metabolizer. Data that Demonstrate a Potential Impact on Pharmacokinetic Properties Only.

What research found

Every published finding on gene variants and Diazepam. Upload your DNA file to see which of these rows apply to you.

Rated evidence (1 rated variant)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3: Level 3. Metabolism/PK. 1.

Metabolism (7 findings)

Studies of how quickly the body processes this medication.

ABCB1 rs1128503: Genotype AA is associated with increased exposure to diazepam in healthy individuals as compared to genotype GG (assigned as normal metabolizer phenotype) .

CYP2B6 CYP2B6 poor metabolizer: CYP2B6 poor metabolizer is associated with decreased clearance of diazepam in healthy individuals as compared to CYP2B6 intermediate metabolizer and normal metabolizer.

CYP2C19 CYP2C19 poor metabolizer: CYP2C19 poor metabolizer is associated with decreased clearance of diazepam in healthy individuals as compared to CYP2C19 normal metabolizer.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3: CYP2C19 *2 + *3 is associated with decreased metabolism of diazepam as compared to CYP2C19 *1.

Response (3 findings)

Studies of how well it worked in people carrying a variant.

CYP2C19 rs12248560: Genotypes CT + TT is associated with decreased clinical benefit to diazepam in men with Alcoholism as compared to genotype CC.

CYP2C19 rs4244285: Genotypes AA + AG is associated with increased clinical benefit to diazepam in men with Alcoholism as compared to genotype GG.

CYP3A4 rs35599367: Genotype GG is associated with increased clinical benefit to diazepam in men with Alcoholism as compared to genotypes AA + AG.

Dosing (2 findings)

Studies of how much of the drug people needed or tolerated.

CYP2C19 CYP2C19*1, CYP2C19*17: CYP2C19 *1/*17 + *17/*17 (assigned as ultrarapid metabolizer phenotype) is not associated with dose of diazepam in people with Alcohol Withdrawal as compared to CYP2C19 normal metabolizer.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17: CYP2C19 *2/*17 + *1/*2 + *1/*3 (assigned as intermediate metabolizer phenotype) is not associated with dose of diazepam in people with Alcohol Withdrawal as compared to CYP2C19 normal metabolizer.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Ativan (Benzodiazepines)

Benzodiazepines (class) (Benzodiazepines)

Byfavo (Benzodiazepines)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com